The Muscarinic Receptor Agonist Xanomeline Has an Antipsychotic-Like Profile in the Rat

2001/11/01 by Kelly J. Stanhope, K.J. Stanhope, N.R. Mirza +23 · 1 citation
Biochemistry, Genetics and Molecular Biology · Neuroscience · #Receptor Mechanisms and Signaling #Neurotransmitter Receptor Influence on Behavior #Neuroscience and Neuropharmacology Research

paper · doi:10.1016/s0022-3565(24)29291-0

Citations

• Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

Cited by

• From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials